301 related articles for article (PubMed ID: 21617218)
21. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
22. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
[TBL] [Abstract][Full Text] [Related]
23. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
24. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
25. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
27. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
Mendonça LS; Firmino F; Moreira JN; Pedroso de Lima MC; Simões S
Bioconjug Chem; 2010 Jan; 21(1):157-68. PubMed ID: 20000596
[TBL] [Abstract][Full Text] [Related]
28. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
[TBL] [Abstract][Full Text] [Related]
29. Targeted lipoplexes for siRNA delivery.
Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
[TBL] [Abstract][Full Text] [Related]
30. siRNA-mediated silencing of Cockayne Cyndrome group B gene potentiates radiation-induced apoptosis and antiproliferative effect in HeLa cells.
Liu F; Yu ZJ; Sui JL; Bai B; Zhou PK
Chin Med J (Engl); 2006 May; 119(9):731-9. PubMed ID: 16701013
[TBL] [Abstract][Full Text] [Related]
31. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
32. [Effect of RNAi-mediated gene silencing of C-erbB-2 on proliferation of lung adenocarcinoma cell line calu-3].
Ren SH; Zhang W; Qu P; Liu Y; Wang JW; Zhang L
Ai Zheng; 2005 Oct; 24(10):1173-8. PubMed ID: 16219128
[TBL] [Abstract][Full Text] [Related]
33. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
[TBL] [Abstract][Full Text] [Related]
34. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
[TBL] [Abstract][Full Text] [Related]
35. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine.
Teng L; Xie J; Teng L; Lee RJ
Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358
[TBL] [Abstract][Full Text] [Related]
36. Insulin-dependent leptin expression in breast cancer cells.
Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
[TBL] [Abstract][Full Text] [Related]
37. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
40. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
